☰

Matthew T. Labenski, Ph.D. - Publications

Affiliations: 
2008 Pharmacology & Toxicology University of Arizona, Tucson, AZ 
Area:
Toxicology
Tree Info Similar researchers PubMed Report error

12 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Cohen JD, Labenski M, Mastrandrea NJ, Canatsey RD, Monks TJ, Lau SS. Transcriptional and post-translational modifications of B-Raf in quinol-thioether induced tuberous sclerosis renal cell carcinoma. Molecular Carcinogenesis. PMID 26333016 DOI: 10.1002/Mc.22366  0.652
2015 Cohen JD, Labenski M, Mastrandrea NJ, Canatsey RD, Monks TJ, Lau SS. Transcriptional and post-translational modifications of B-Raf in quinol-thioether induced tuberous sclerosis renal cell carcinoma Molecular Carcinogenesis. DOI: 10.1002/mc.22366  0.648
2014 Brown JM, Kuhlman C, Terneus MV, Labenski MT, Lamyaithong AB, Ball JG, Lau SS, Valentovic MA. S-adenosyl-l-methionine protection of acetaminophen mediated oxidative stress and identification of hepatic 4-hydroxynonenal protein adducts by mass spectrometry. Toxicology and Applied Pharmacology. 281: 174-84. PMID 25246065 DOI: 10.1016/J.Taap.2014.08.027  0.661
2013 Nacht M, Qiao L, Sheets MP, St Martin T, Labenski M, Mazdiyasni H, Karp R, Zhu Z, Chaturvedi P, Bhavsar D, Niu D, Westlin W, Petter RC, Medikonda AP, Singh J. Discovery of a potent and isoform-selective targeted covalent inhibitor of the lipid kinase PI3Kα. Journal of Medicinal Chemistry. 56: 712-21. PMID 23360348 DOI: 10.1021/Jm3008745  0.309
2011 Fisher AA, Labenski MT, Malladi S, Chapman JD, Bratton SB, Monks TJ, Lau SS. The frequency of 1,4-benzoquinone-lysine adducts in cytochrome c correlate with defects in apoptosome activation. Toxicological Sciences : An Official Journal of the Society of Toxicology. 122: 64-72. PMID 21527774 DOI: 10.1093/Toxsci/Kfr085  0.682
2011 Labenski MT, Fisher AA, Monks TJ, Lau SS. Identification of chemical-adducted proteins in urine by multi-dimensional protein identification technology (LC/LC-MS/MS). Methods in Molecular Biology (Clifton, N.J.). 691: 339-47. PMID 20972764 DOI: 10.1007/978-1-60761-849-2_21  0.689
2011 Labenski MT, Fisher AA, Monks TJ, Lau SS. One-dimensional western blotting coupled to LC-MS/MS analysis to identify chemical-adducted proteins in rat urine. Methods in Molecular Biology (Clifton, N.J.). 691: 327-38. PMID 20972763 DOI: 10.1007/978-1-60761-849-2_20  0.732
2011 Fisher AA, Labenski MT, Monks TJ, Lau SS. Utilization of LC-MS/MS analyses to identify site-specific chemical protein adducts in vitro. Methods in Molecular Biology (Clifton, N.J.). 691: 317-26. PMID 20972762 DOI: 10.1007/978-1-60761-849-2_19  0.72
2011 Fisher AA, Labenski MT, Monks TJ, Lau SS. Utilization of MALDI-TOF to determine chemical-protein adduct formation in vitro. Methods in Molecular Biology (Clifton, N.J.). 691: 303-16. PMID 20972761 DOI: 10.1007/978-1-60761-849-2_18  0.675
2011 Qiao L, Nacht M, Sheets MP, Martin TS, Labenski M, Mazdiyasni H, Zhu Z, Chaturvedi P, Bhavsar D, Niu D, Westlin W, Petter R, Singh J. Abstract 4482: Discovery of an irreversible PI3Kα-specific Inhibitor Cancer Research. 71: 4482-4482. DOI: 10.1158/1538-7445.Am2011-4482  0.357
2009 Labenski MT, Fisher AA, Lo HH, Monks TJ, Lau SS. Protein electrophile-binding motifs: lysine-rich proteins are preferential targets of quinones. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 37: 1211-8. PMID 19251821 DOI: 10.1124/Dmd.108.026211  0.694
2007 Fisher AA, Labenski MT, Malladi S, Gokhale V, Bowen ME, Milleron RS, Bratton SB, Monks TJ, Lau SS. Quinone electrophiles selectively adduct "electrophile binding motifs" within cytochrome c. Biochemistry. 46: 11090-100. PMID 17824617 DOI: 10.1021/Bi700613W  0.704
Show low-probability matches.